Over the last 12 months, Palisade Bio insiders reported 3 buys totaling $250K and 2 sales totaling $410K across SEC Form 4 filings.
| Date | Insider | Type | Shares | Avg price | Value | Δ stake | Marks |
|---|---|---|---|---|---|---|---|
| Jul 9, 2026 | Baltera Robert Jr.D | ▲ Buy | 45,000 | $1.97 | $89K | +10.8% | 2 tranches |
| Jul 7, 2026 | Baltera Robert Jr.D | ▲ Buy | 50,000 | $2.04 | $102K | +13.6% | 2 tranches |
| Jul 7, 2026 | Jones Mitchell LawrenceChief Medical Officer · O | ▼ Sale | 51,880 | $2.05 | $107K | -35.6% | — |
| Jul 7, 2026 | Finley John DavidCEO, CFO · O·D | ▼ Sale | 146,798 | $2.07 | $303K | -40.3% | — |
| Jul 2, 2026 | Baltera Robert Jr.D | ▲ Buy | 30,000 | $1.98 | $59K | +8.9% | 2 tranches |
Corporate insiders — officers, directors and 10%+ owners — must report their trades to the SEC on Form 4 within two business days. We group each filing's transactions into one economic event (a laddered 10b5-1 sale is one event, not 25 rows), flag pre-arranged plans and late filings, and link every event to its AI-scored article in the $PALI feed.